Innoviva News and Activities

Presence

Innoviva is a pharmaceutical company that invests in and manages medicines and royalty assets. Its products and services support patients, healthcare providers, and pharmaceutical partners in respiratory and infectious disease care.

Innoviva products and services overview:

Respiratory therapies
Infectious disease treatments
Critical care products
Royalty assets
Healthcare investments

Revenue: ~$350 million

Employees: 110

Headquarters: Burlingame, United States (USA)

Innoviva is one of the...

Innoviva is a company listed under the stock ticker INVA (US).

They are in:

Pharmaceuticals50%
Biotechnology50%

Executives

View the org chart displaying its 19 main executives

Most searched biographies at Innoviva

Popular executive movements at Innoviva

Derek Small, Director, has left the company (posted on May 19 2026).
Josephine Linden has joined the company as Director (posted on May 19 2026).
Mark DiPaolo, Chairman of the Board, has left the company (posted on May 19 2026).

Create your alert
to follow the executive moves at Innoviva.